CH636337A5 - Process for preparing novel amines having beta receptor-inhibiting activity - Google Patents

Process for preparing novel amines having beta receptor-inhibiting activity Download PDF

Info

Publication number
CH636337A5
CH636337A5 CH1230577A CH1230577A CH636337A5 CH 636337 A5 CH636337 A5 CH 636337A5 CH 1230577 A CH1230577 A CH 1230577A CH 1230577 A CH1230577 A CH 1230577A CH 636337 A5 CH636337 A5 CH 636337A5
Authority
CH
Switzerland
Prior art keywords
ethylamino
hydroxyphenoxy
acid
compounds
formula
Prior art date
Application number
CH1230577A
Other languages
German (de)
English (en)
Inventor
Enar Ingemar Carlsson
Gustav Benny Roger Samuelsson
Bo Torsten Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CH636337A5 publication Critical patent/CH636337A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH1230577A 1976-10-07 1977-10-07 Process for preparing novel amines having beta receptor-inhibiting activity CH636337A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (1)

Publication Number Publication Date
CH636337A5 true CH636337A5 (en) 1983-05-31

Family

ID=20329066

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1230577A CH636337A5 (en) 1976-10-07 1977-10-07 Process for preparing novel amines having beta receptor-inhibiting activity

Country Status (22)

Country Link
JP (1) JPS5346928A (hr)
AT (1) AT351509B (hr)
AU (1) AU516727B2 (hr)
BE (1) BE859474A (hr)
CA (1) CA1093096A (hr)
CH (1) CH636337A5 (hr)
CS (5) CS208730B2 (hr)
DD (1) DD132195A5 (hr)
DE (1) DE2743493A1 (hr)
DK (1) DK145375C (hr)
FI (1) FI772936A (hr)
FR (1) FR2367054A1 (hr)
GB (1) GB1589838A (hr)
HU (1) HU177638B (hr)
IE (1) IE45938B1 (hr)
LU (1) LU78263A1 (hr)
NL (1) NL7710941A (hr)
NO (1) NO145436C (hr)
NZ (1) NZ185318A (hr)
SE (1) SE416545B (hr)
SU (3) SU735166A3 (hr)
ZA (1) ZA775603B (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (hr) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
AU516727B2 (en) 1981-06-18
DK443177A (da) 1978-04-08
BE859474A (fr) 1978-04-07
DK145375C (da) 1983-04-11
CS208731B2 (en) 1981-09-15
NZ185318A (en) 1980-02-21
SU735166A3 (ru) 1980-05-15
SE7611125L (sv) 1978-04-08
AU2930077A (en) 1979-04-12
NO773406L (no) 1978-04-10
LU78263A1 (hr) 1978-06-09
CS208734B2 (en) 1981-09-15
CS208732B2 (en) 1981-09-15
FR2367054B1 (hr) 1981-11-06
AT351509B (de) 1979-07-25
HU177638B (en) 1981-11-28
DK145375B (da) 1982-11-08
DD132195A5 (de) 1978-09-06
CA1093096A (en) 1981-01-06
NO145436B (no) 1981-12-14
IE45938L (en) 1978-04-07
CS208730B2 (en) 1981-09-15
IE45938B1 (en) 1983-01-12
FR2367054A1 (fr) 1978-05-05
DE2743493A1 (de) 1978-04-13
GB1589838A (en) 1981-05-20
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
NL7710941A (nl) 1978-04-11
CS208733B2 (en) 1981-09-15
SU959623A3 (ru) 1982-09-15
SU784760A3 (ru) 1980-11-30
FI772936A (fi) 1978-04-08
ATA702177A (de) 1979-01-15
ZA775603B (en) 1978-06-28
SE416545B (sv) 1981-01-19

Similar Documents

Publication Publication Date Title
EP0400011B1 (de) Neue phenylethanolamine
DE1643262C3 (de) i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0152944A2 (de) Verwendung von Adenosin-Derivaten als Antiallergica und Arzneimittel, die diese enthalten
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
CH616648A5 (hr)
EP0074014B1 (de) 2-(2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, seine Säureadditionssalze, Verfahren zu seiner Herstellung und Arzneimittel
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE68910211T2 (de) Estramustin-ester.
CH372667A (de) Verfahren zur Herstellung von 3-Aryl-3-pyrrolidinolen
CH622490A5 (en) Process for the preparation of novel hydroxypropylamines
CH636337A5 (en) Process for preparing novel amines having beta receptor-inhibiting activity
DD144665A5 (de) Verfahren zur herstellung von 1-phenoxy-3-aminopropan-2-olen
EP0081748A2 (de) Verfahren zur Herstellung von (-)-2-(1-(2,6-Dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en
DE2000030A1 (de) 3-Alkoxy- und 3-Aryloxy-2-(diaryl-hydroxy)-methylpropylamine,ein Verfahren zu ihrer Herstellung und ihre Verwendung
EP1102746B1 (de) Substituierte phenylamidine mit antithrombotischer wirkung
CH632987A5 (en) Process for preparing novel amines
CH632986A5 (en) Process for preparing novel amines
DE2522218B2 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
AT345790B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1- aminopropanen und deren saeureaddtionssalzen
AT363067B (de) Verfahren zur herstellung von neuen 3-phenoxy-2-hydroxy-1-phenoxy- oder -1-phenylthioalkylamino-propanen und von deren saeureadditionssalzen
EP0225543A1 (de) Basisch substituierte Phenylacetaldehyde, ihre Herstellung und diese enthaltende Arzneimittel
CH618416A5 (en) Process for the preparation of novel hydroxyamines
DE2738131A1 (de) Aminoketone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3787319T2 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE2102246C3 (hr)

Legal Events

Date Code Title Description
PL Patent ceased